The USFDA inspectors issued the observations after a product pre-approval inspection of the biologics facility in Bachupally
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The inspection closed with zero observations and a classification of No Action Indicated
Subscribe To Our Newsletter & Stay Updated
